Paracetamol in every dosage form — with pediatric dosage design (syrups, suspensions) and suppository technology for patients who cannot take orals.
Fever and pain are the most common reasons patients anywhere reach for a medicine — and children need formulations designed for them, not just smaller tablets. Artemisine Medicines Technology controls the whole paracetamol value chain — 5,000 tons per year of paracetamol API (DML No. Jin20160069) feeding our own finished-dosage lines — which means stable supply, stable cost and full batch traceability.
Our pediatric dosage design covers paracetamol syrups, oral solutions and suspensions with accurate mg/mL strengths, palatable flavours and dosing devices for safe administration by weight bands — plus ibuprofen oral suspension for pediatric fever. For patients who cannot take oral medicines (vomiting, peri-operative, infants), our suppository technology delivers paracetamol, ibuprofen, artesunate and diclofenac in stable, fast-release fatty-base suppositories manufactured on dedicated lines.
The adult range completes the family: paracetamol 500 mg tablets, effervescent tablets, paracetamol injection for hospital IV use, aspirin 300 mg and diclofenac sodium tablets and injection. All products are GMP manufactured, released to BP / enterprise standards and shipped with COA, COPP, DMF and CTD dossiers for OTC registration in 50+ countries.
All products are GMP manufactured and supplied with COA, COPP, DMF and CTD dossiers. Tap any product for specifications and WHO prescribing guidance.
Tell us your target market and annual volume — our export team replies within 24 hours.
Paracetamol syrups and oral solutions (120–325 mg strengths), paracetamol oral suspension, ibuprofen oral suspension — all designed with pediatric-appropriate concentrations, palatability and dosing accuracy.
Paracetamol 150 mg, ibuprofen 50 mg, diclofenac and artesunate 100 mg suppositories, produced on dedicated suppository lines with controlled melting profiles and batch release testing.
Yes. Artemisine holds DML No. Jin20160069 for paracetamol API with 5,000 tons annual capacity, available with COA and DMF for formulation manufacturers.
Ibuprofen (tablets, suspension, suppository), aspirin 300 mg tablets, and diclofenac sodium (tablets 50 mg, injection 75 mg/3 mL) — covering both OTC and prescription analgesic segments.
Artemisine Medicines